Arcutis Biotherapeutics
ARQT
$8.47
Share price
-1.40%
Change (1 day)
-39.06%
Change (1 year)
Categories
P/S ratio for Arcutis Biotherapeutics (ARQT)
P/S ratio as of April 2024 (TTM): 16.3
According to Arcutis Biotherapeutics's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 16.347. At the end of 2023 the company had a P/S ratio of 5.11.
P/S ratio history for Arcutis Biotherapeutics from 2020 to 2023
PS ratio at the end of each year
| Year | P/S ratio | Change |
|---|---|---|
| 2023 | 5.11 | -97.91% |
| 2022 | 245 | |
| 2021 | N/A | |
| 2020 | N/A |
P/S ratio for similar companies or competitors
| Company | P/S ratio | P/S ratio differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | N/A | N/A | 🇺🇸 USA |